Passage BIO, Inc. Files 8-K
Ticker: PASG · Form: 8-K · Filed: Apr 20, 2026 · CIK: 0001787297
Sentiment: neutral
Topics: disclosure, filing, regulation-fd
TL;DR
Passage BIO filed an 8-K on 4/20/26, check exhibits for details.
AI Summary
Passage BIO, Inc. filed an 8-K on April 20, 2026, to disclose information under Regulation FD. The filing includes exhibits such as financial statements and other documents, but no specific financial figures or material events were detailed in the provided text.
Why It Matters
This filing indicates Passage BIO, Inc. is providing updates or disclosures to the public, which could contain material information for investors.
Risk Assessment
Risk Level: low — The filing is a routine disclosure and does not contain specific negative or positive material events.
Key Players & Entities
- Passage BIO, Inc. (company) — Filer of the 8-K
- 0001787297 (company) — CIK number for Passage BIO, Inc.
- 0001104659-26-045219 (company) — SEC Accession Number for the filing
- 2026-04-20 (date) — Filing Date and Period of Report
FAQ
What is the purpose of this 8-K filing by Passage BIO, Inc.?
The 8-K filing on April 20, 2026, is for Regulation FD Disclosure (Item 7.01) and includes Financial Statements and Exhibits (Item 9.01).
What specific financial information is provided in the filing?
The provided text does not detail specific financial figures; it only lists 'Financial Statements and Exhibits' as part of the filing.
When was this 8-K filing accepted by the SEC?
The filing was accepted on April 20, 2026, at 07:15:35.
What are the document types included in this filing?
The filing includes a FORM 8-K, EXHIBIT 99.1, EXHIBIT 99.2, and numerous GRAPHIC files.
Does the filing mention any specific material events or transactions?
The filing is categorized under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits), but the provided text does not specify any particular material events.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 20, 2026 regarding Passage BIO, Inc. (PASG).